Laboratorios LAM

What Laboratorios LAM does

Laboratorios LAM (legal name: Laboratorio de Aplicaciones Médicas, S.A.) is a privately held Dominican Republic pharmaceutical manufacturer founded in 1983, headquartered in Santo Domingo with a branch office in Santiago. The company manufactures and distributes a broad portfolio of generic medications across more than fourteen therapeutic categories, including antibiotics, cardiology, metabolic (with a heavy emphasis on diabetes formulations such as metformin, glimepiride, vildagliptin, and dapagliflozin), neurology, oncology, urology, gastroenterology, pain management, psychiatry, pediatrics (including infant nutrition products such as Milkids), OTC, and personal care. The portfolio spans standalone molecules and combination therapies across multiple dosage strengths, distributed as prescription and OTC products.

The company's core technology is pharmaceutical manufacturing supported by a quality management function (Gestión de Calidad) and an in-house production plant (Planta de Producción), with no AI/ML capabilities disclosed. Go-to-market is sales-led: a field sales force targets healthcare professionals (doctors, pharmacists) and medical institutions across the Dominican Republic, supported by medical education conferences, a corporate website (lam.com.do), active social media presence, and newsletter subscriptions. Distribution is exclusively domestic through pharmacy networks and direct supply to hospitals and clinics, with no international footprint identified.

Revenue is generated through one-time sales of pharmaceutical products. Pricing is not publicly disclosed, and product information is gated for healthcare professionals. The company is privately held with no institutional investors, parent company, subsidiaries, funding rounds, or M&A activity identified. Recent activity centers on medical education partnerships (Mount Sinai Hospital NY in 2024-10, Dr. Ashutosh Tewari in 2025-06) and CSR initiatives through Fundación LAM (Dominican Alzheimer's Association in 2025-03, Heart Care Dominicana since at least 2019).

Name

Laboratorios LAM

Legal name

Laboratorio de Aplicaciones Médicas, S.A.

Website

https://lam.com.do

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

251–500 employees

Short description

Laboratorios LAM is a Dominican Republic pharmaceutical manufacturer founded in 1983 that produces and distributes generic medications across 14-plus therapeutic categories through pharmacy networks and medical institutions, serving healthcare professionals and patients domestically.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Therapeutic products
• Prescription drugs
• Drug distribution

Headquarters

HQ city

Santo Domingo

HQ country

Dominican Republic

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Laboratorios LAM generates revenue through the manufacture and sale of pharmaceutical products including prescription medications and over-the-counter drugs across therapeutic categories such as antibiotics, cardiology, metabolic, neurology, oncology, and more.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Laboratorios LAM manufactures and distributes a broad portfolio of generic pharmaceutical products across multiple therapeutic categories including antibiotics, cardiology, metabolic (diabetes), neurology, oncology, OTC, pediatrics, psychiatry, urology, pain management, and gastroenterology. The company operates production facilities in Santo Domingo and Santiago, Dominican Republic, producing both standalone medications and combination therapies, as well as pediatric nutrition products.

Product overview

Laboratorios LAM (Laboratorio de Aplicaciones Medicas, S.A.) is a Dominican Republic pharmaceutical company that manufactures and distributes a broad portfolio of generic medications. The company operates from production facilities in Santo Domingo and Santiago, offering products across multiple therapeutic classes including antibiotics, cardiology, personal care, pain management, gastroenterology, metabolic (diabetes), neurology, oncology, OTC, pediatrics, psychiatry, urology, and various other categories. The product portfolio includes standalone medications (such as Metformin formulations, Fluconazole, Azithromycin) as well as combination therapies (such as Bisocor Plus D, Gaflox Duo, Glucox combinations). The company also produces pediatric nutrition products like Milkids for infants, demonstrating diversification beyond traditional pharmaceutical formulations.

Differentiator

Problem solved

Functional benefit

Products and services

• Metformina 850/96 Metformin medication for metabolic conditions, specifically diabetes management.
• Fluconazol 150 Fluconazole antifungal medication used for urological infections.
• Glucox 500 Metformin hydrochloride medication for diabetes treatment.
• Metformina XR 500 Extended-release metformin formulation for prolonged diabetes management.
• Flutamid 250 Flutamide medication for oncology treatment.
• Glucox XR 500 Extended-release metformin hydrochloride for sustained diabetes control.
• Glucox 850 Metformin hydrochloride medication at 850mg dosage for diabetes management.
• Xitrox 500 Azithromycin antibiotic for pediatric applications.
• Xigdara 10 mg Dapagliflozin medication for metabolic conditions including diabetes.
• Gaflox Duo Combination medication with Tamsulosin and Dutasteride for urological conditions.
• Glucox 2G/500 Metformin combination medication for enhanced diabetes management.
• Glimeryl 4 Glimepiride medication for diabetes treatment.
• Milkids 1 de 0-6 meses 800 gr Infant nutrition product for babies aged 0-6 months.
• Metformina XR 750 Extended-release metformin at 750mg dosage for sustained diabetes control.
• Binusyl 150 Bicalutamide medication for oncology treatment.
• Metformina XR 1000 Extended-release metformin at 1000mg dosage for advanced diabetes management.
• Glimeryl 2 Glimepiride medication at 2mg dosage for diabetes treatment.
• Droxicin 25 Hydroxyzine medication for allergy and anxiety treatment.
• Vildagliptina 50 Vildagliptin medication for diabetes management.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered major and minor.

• Dr. Ashutosh TewarimajorStrategic or Co-development Partner · 26 June 2025Laboratorios LAM brought Dr. Ashutosh Tewari to the Dominican Republic for a Magistral Conference on masculine health, reaffirming their commitment to continuous medical education.
• Fundación LAMmajorOthers · 25 March 2025Fundación LAM signed a collaboration agreement with the Dominican Association of Alzheimer to strengthen mental health and wellbeing initiatives in the country.
• Laboratorios CardiopharmmajorStrategic or Co-development Partner · 1 October 2024Laboratorios LAM and Laboratorios Cardiopharm collaborated with Mount Sinai Hospital NY to advance valvular reconstruction surgery in Santo Domingo.
• Mount Sinai Hospital (New York)majorStrategic or Co-development Partner · 1 October 2024Collaboration with Mount Sinai Hospital NY on valvular reconstruction surgery advances, bringing international expertise to Dominican Republic.
• Fundación Heart Care DominicanamajorStrategic or Co-development Partner · 25 September 2019Laboratorios Lam sponsors Fundación Heart Care Dominicana's cardiovascular health routes, providing transportation, medical supplies, medications, and supporting cardiac care for underserved populations. Sponsored 17th Ruta de Salud Cardiovascular attending over 600 patients.
• SENASAminorOthersSENASA facilitated enrollment of uninsured patients in subsidized health plans during cardiovascular health routes.

Scale indicators1 record

Recent moves2 records

Expansion highlights4 records

Broad incumbents

• Eurofarma: Brazilian pharmaceutical company with manufacturing and broad generic and branded portfolio across multiple Latin American markets. Comparable as a multi-country LatAm pharma manufacturer with similar therapeutic categories.
• Laboratorios Roemmers: Major Argentine pharmaceutical company with broad therapeutic-area coverage across Latin America. Comparable in product breadth and Latin American footprint, though materially larger than Laboratorios LAM.
• Laboratorios Bagó: Argentine multinational pharmaceutical manufacturer with broad therapeutic categories (cardiology, CNS, infectious disease, etc.) distributed across Latin America. Similar operating model and therapeutic breadth.

Direct peers

• Procaps: Colombian-integrated pharmaceutical company with generic drug manufacturing and broad therapeutic portfolio across Latin America. Comparable as a regional Latin American generics manufacturer of similar breadth to Laboratorios LAM.
• Laboratorios Richmond: Argentine pharmaceutical company with generics and branded generics across multiple therapeutic areas. Comparable in portfolio diversity and regional manufacturing-distribution model.
• GENFAR: Latin American generic pharmaceutical manufacturer focused on affordable, broad-spectrum generic drugs across therapeutic categories. Comparable as a multi-category generics manufacturer in the same regional market dynamic.

Regional players

• Laboratorios Stein: Costa Rican pharmaceutical manufacturer with presence across Central America and the Caribbean. Comparable as a smaller regional LatAm pharma manufacturer with broad generics portfolio serving neighboring markets.
• Asofarma: Mexican pharmaceutical company with generics and specialty products across Latin America. Comparable in therapeutic breadth and in operating as a regional LatAm pharma manufacturer outside the largest economies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/LaboratoriosLAM
• YouTubeyoutube.com/user/LaboratoriosLAM?feature=mhum
• Facebookfacebook.com/LaboratoriosLAMRD
• LinkedInlinkedin.com/company/laboratorios-lam
• Instagraminstagram.com/LaboratoriosLam

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios LAM